Twist Bioscience Corp — Director's Dealing 2019

Oct 15, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2019-10-11

Reporting Person: Finn Patrick John (SVP, Commercial Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-11	Common Stock	M	34000	$1.19	Acquired	39002	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-11	Employee Stock Option (right to buy)	$1.19	M	34000	Disposed	2025-02-03	Common Stock (34000)	Direct

Footnotes

F1: The option is immediately exercisable. 25% of the shares subject to the option vested on February 2, 2016, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.